![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MCM5 |
Gene summary for MCM5 |
![]() |
Gene information | Species | Human | Gene symbol | MCM5 | Gene ID | 4174 |
Gene name | minichromosome maintenance complex component 5 | |
Gene Alias | CDC46 | |
Cytomap | 22q12.3 | |
Gene Type | protein-coding | GO ID | GO:0000724 | UniProtAcc | B1AHB0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4174 | MCM5 | HTA11_3361_2000001011 | Human | Colorectum | AD | 5.49e-03 | 3.02e-01 | -0.1207 |
4174 | MCM5 | HTA11_83_2000001011 | Human | Colorectum | SER | 3.33e-02 | 2.14e-01 | -0.1526 |
4174 | MCM5 | HTA11_696_2000001011 | Human | Colorectum | AD | 7.69e-05 | 2.63e-01 | -0.1464 |
4174 | MCM5 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.18e-07 | 2.98e-01 | -0.059 |
4174 | MCM5 | HTA11_546_2000001011 | Human | Colorectum | AD | 3.63e-04 | 3.30e-01 | -0.0842 |
4174 | MCM5 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.56e-05 | 2.49e-01 | 0.096 |
4174 | MCM5 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.46e-07 | 2.38e-01 | 0.0674 |
4174 | MCM5 | LZE2T | Human | Esophagus | ESCC | 1.51e-07 | 5.37e-01 | 0.082 |
4174 | MCM5 | LZE4T | Human | Esophagus | ESCC | 2.73e-09 | 2.74e-01 | 0.0811 |
4174 | MCM5 | LZE7T | Human | Esophagus | ESCC | 4.02e-16 | 9.11e-01 | 0.0667 |
4174 | MCM5 | LZE8T | Human | Esophagus | ESCC | 1.14e-05 | 3.51e-01 | 0.067 |
4174 | MCM5 | LZE22T | Human | Esophagus | ESCC | 9.94e-07 | 6.49e-01 | 0.068 |
4174 | MCM5 | LZE24T | Human | Esophagus | ESCC | 1.73e-11 | 3.36e-01 | 0.0596 |
4174 | MCM5 | LZE21T | Human | Esophagus | ESCC | 2.19e-08 | 5.78e-01 | 0.0655 |
4174 | MCM5 | LZE6T | Human | Esophagus | ESCC | 9.65e-12 | 5.04e-01 | 0.0845 |
4174 | MCM5 | P1T-E | Human | Esophagus | ESCC | 6.81e-05 | 5.89e-01 | 0.0875 |
4174 | MCM5 | P2T-E | Human | Esophagus | ESCC | 4.31e-42 | 1.01e+00 | 0.1177 |
4174 | MCM5 | P4T-E | Human | Esophagus | ESCC | 3.68e-15 | 4.18e-01 | 0.1323 |
4174 | MCM5 | P5T-E | Human | Esophagus | ESCC | 6.33e-16 | 3.34e-01 | 0.1327 |
4174 | MCM5 | P8T-E | Human | Esophagus | ESCC | 7.61e-19 | 5.25e-01 | 0.0889 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0006270 | Oral cavity | OSCC | DNA replication initiation | 25/7305 | 34/18723 | 4.63e-05 | 3.90e-04 | 25 |
GO:0006310 | Oral cavity | OSCC | DNA recombination | 147/7305 | 305/18723 | 6.33e-04 | 3.56e-03 | 147 |
GO:0000725 | Oral cavity | OSCC | recombinational repair | 70/7305 | 140/18723 | 5.22e-03 | 2.03e-02 | 70 |
GO:0000724 | Oral cavity | OSCC | double-strand break repair via homologous recombination | 69/7305 | 138/18723 | 5.52e-03 | 2.14e-02 | 69 |
GO:0000727 | Oral cavity | OSCC | double-strand break repair via break-induced replication | 9/7305 | 12/18723 | 1.27e-02 | 4.24e-02 | 9 |
GO:000626011 | Oral cavity | LP | DNA replication | 97/4623 | 260/18723 | 3.67e-06 | 7.75e-05 | 97 |
GO:000630211 | Oral cavity | LP | double-strand break repair | 80/4623 | 251/18723 | 5.81e-03 | 3.46e-02 | 80 |
GO:003239213 | Oral cavity | LP | DNA geometric change | 33/4623 | 90/18723 | 7.51e-03 | 4.15e-02 | 33 |
GO:000626012 | Skin | cSCC | DNA replication | 106/4864 | 260/18723 | 1.18e-07 | 2.77e-06 | 106 |
GO:003239215 | Skin | cSCC | DNA geometric change | 44/4864 | 90/18723 | 2.53e-06 | 4.06e-05 | 44 |
GO:003250814 | Skin | cSCC | DNA duplex unwinding | 40/4864 | 84/18723 | 1.58e-05 | 1.94e-04 | 40 |
GO:00063025 | Skin | cSCC | double-strand break repair | 89/4864 | 251/18723 | 5.23e-04 | 3.92e-03 | 89 |
GO:00711031 | Skin | cSCC | DNA conformation change | 96/4864 | 290/18723 | 3.87e-03 | 2.07e-02 | 96 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0411023 | Esophagus | ESCC | Cell cycle | 126/4205 | 157/8465 | 1.34e-15 | 5.60e-14 | 2.87e-14 | 126 |
hsa030304 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa0411033 | Esophagus | ESCC | Cell cycle | 126/4205 | 157/8465 | 1.34e-15 | 5.60e-14 | 2.87e-14 | 126 |
hsa0303011 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa041104 | Liver | Cirrhotic | Cell cycle | 61/2530 | 157/8465 | 9.53e-03 | 3.21e-02 | 1.98e-02 | 61 |
hsa0411011 | Liver | Cirrhotic | Cell cycle | 61/2530 | 157/8465 | 9.53e-03 | 3.21e-02 | 1.98e-02 | 61 |
hsa041102 | Liver | HCC | Cell cycle | 106/4020 | 157/8465 | 2.54e-07 | 3.04e-06 | 1.69e-06 | 106 |
hsa041103 | Liver | HCC | Cell cycle | 106/4020 | 157/8465 | 2.54e-07 | 3.04e-06 | 1.69e-06 | 106 |
hsa041108 | Oral cavity | OSCC | Cell cycle | 118/3704 | 157/8465 | 7.15e-16 | 2.66e-14 | 1.35e-14 | 118 |
hsa03030 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa0411015 | Oral cavity | OSCC | Cell cycle | 118/3704 | 157/8465 | 7.15e-16 | 2.66e-14 | 1.35e-14 | 118 |
hsa030301 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa030302 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa0411022 | Oral cavity | LP | Cell cycle | 70/2418 | 157/8465 | 1.17e-05 | 8.27e-05 | 5.33e-05 | 70 |
hsa030303 | Oral cavity | LP | DNA replication | 23/2418 | 36/8465 | 1.08e-05 | 7.79e-05 | 5.02e-05 | 23 |
hsa0411032 | Oral cavity | LP | Cell cycle | 70/2418 | 157/8465 | 1.17e-05 | 8.27e-05 | 5.33e-05 | 70 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MCM5 | SNV | Missense_Mutation | novel | c.1421N>C | p.Ile474Thr | p.I474T | P33992 | protein_coding | deleterious(0) | probably_damaging(0.937) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MCM5 | insertion | Frame_Shift_Ins | novel | c.1174_1175insGGGGCAC | p.Lys392ArgfsTer56 | p.K392Rfs*56 | P33992 | protein_coding | TCGA-A2-A04Y-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
MCM5 | insertion | Nonsense_Mutation | novel | c.1176_1177insACATGAAGAAGGCCATTGCCTGCC | p.Lys392_Phe393insThrTerArgArgProLeuProAla | p.K392_F393insT*RRPLPA | P33992 | protein_coding | TCGA-A2-A04Y-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
MCM5 | SNV | Missense_Mutation | rs149623832 | c.1627N>A | p.Ala543Thr | p.A543T | P33992 | protein_coding | tolerated(0.08) | possibly_damaging(0.869) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
MCM5 | SNV | Missense_Mutation | novel | c.1777G>A | p.Ala593Thr | p.A593T | P33992 | protein_coding | tolerated(0.12) | benign(0.031) | TCGA-C5-A8XH-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
MCM5 | SNV | Missense_Mutation | c.598G>A | p.Asp200Asn | p.D200N | P33992 | protein_coding | tolerated(0.43) | benign(0.001) | TCGA-EA-A6QX-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | |
MCM5 | SNV | Missense_Mutation | c.2170N>T | p.Arg724Cys | p.R724C | P33992 | protein_coding | deleterious(0) | probably_damaging(0.939) | TCGA-Q1-A6DV-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
MCM5 | SNV | Missense_Mutation | c.1069C>T | p.Leu357Phe | p.L357F | P33992 | protein_coding | deleterious(0) | probably_damaging(0.961) | TCGA-AA-3715-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
MCM5 | SNV | Missense_Mutation | c.475N>G | p.Ser159Ala | p.S159A | P33992 | protein_coding | deleterious(0.02) | benign(0.013) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MCM5 | SNV | Missense_Mutation | c.518N>A | p.Arg173His | p.R173H | P33992 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-D5-6930-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |